Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209–13.
2. Ferløv Baselius NJ, Brynskov T, Falk MK, Sørensen TL, Subhi Y. Driving vision in patients with neovascular AMD in anti-VEGF treatment. Acta Ophthalmol. 2021;99:e1360–5.
3. Review of Ophthalmology. IVT Injections: Health Policy Implications. Available from https://www.reviewofophthalmology.com/article/ivt-injections-health-policy-implications. Accessed 6 November 2023.
4. Jørstad ØK, Steffensen LA, Eriksen K, Bragadóttir R, Moe MC. Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway. Acta Ophthalmol. 2020;98:774–9.
5. Thinggaard BS, Pedersen F, Grauslund J, Stokholm L. Intravitreal vascular endothelial growth factor inhibitor therapy in Denmark and 5-year projections. JAMA Netw Open. 2023;6: e2335148.